{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T12:52:51Z","timestamp":1785243171318,"version":"3.55.0"},"reference-count":35,"publisher":"Impact Journals, LLC","issue":"42","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,9,22]]},"DOI":"10.18632\/oncotarget.20046","type":"journal-article","created":{"date-parts":[[2017,8,8]],"date-time":"2017-08-08T21:56:47Z","timestamp":1502229407000},"page":"72147-72156","source":"Crossref","is-referenced-by-count":52,"title":["Drug repositioning of mevalonate pathway inhibitors as antitumor agents for ovarian cancer"],"prefix":"10.18632","volume":"8","author":[{"given":"Yusuke","family":"Kobayashi","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Keio University School of Medicine, Tokyo, Japan"},{"name":"Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyasu","family":"Kashima","sequence":"additional","affiliation":[{"name":"Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America"},{"name":"Department of Obstetrics and Gynecology, Shinshu University School of Medicine, Nagano, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohan Suryo","family":"Rahmanto","sequence":"additional","affiliation":[{"name":"Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kouji","family":"Banno","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Keio University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America"},{"name":"School of Pharmacy, Curtin Health Innovation Research Institute, Curtin University, Perth, Western Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Matoba","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Keio University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiko","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Keio University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moito","family":"Iijima","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Keio University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Takeda","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Keio University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruko","family":"Kunitomi","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Keio University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miho","family":"Iida","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Keio University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masataka","family":"Adachi","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Keio University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanako","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Keio University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosuke","family":"Tsuji","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Keio University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenta","family":"Masuda","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Keio University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Nomura","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Keio University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiichiro","family":"Tominaga","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Keio University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Aoki","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Keio University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2017,8,7]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3322\/caac.21262","article-title":"Global cancer statistics, 2012","volume":"65","author":"Jemal","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijgo.2013.10.001","article-title":"Staging classification for cancer of the ovary, fallopian tube, and peritoneum","volume":"124","author":"Prat","year":"2014","journal-title":"Int J Gynaecol Obstet"},{"key":"3","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.ajpath.2015.11.011","article-title":"The Dualistic Model of Ovarian Carcinogenesis: Revisited, Revised, and Expanded","volume":"186","author":"Shih Ie","year":"2016","journal-title":"Am J Pathol"},{"key":"4","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.2174\/1568026616666160216153618","article-title":"An Insight into Drug Repositioning for the Development of Novel Anti-Cancer Drugs","volume":"16","author":"Choi","year":"2016","journal-title":"Curr Top Med Chem"},{"key":"5","volume-title":"Endotext","author":"Singer","year":"2000"},{"key":"6","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0140-6736(05)67394-1","article-title":"Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins","volume":"366","author":"Simes","year":"2005","journal-title":"Lancet"},{"key":"7","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1056\/NEJMoa043792","article-title":"Statins and the risk of colorectal cancer","volume":"352","author":"Rennert","year":"2005","journal-title":"N Engl J Med"},{"key":"8","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1056\/NEJMoa1201735","article-title":"Statin use and reduced cancer-related mortality","volume":"367","author":"Bojesen","year":"2012","journal-title":"N Engl J Med"},{"key":"9","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.1200\/JCO.2013.54.4569","article-title":"Statin use after colorectal cancer diagnosis and survival: a population-based cohort study","volume":"32","author":"Murray","year":"2014","journal-title":"J Clin Oncol"},{"key":"10","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1200\/JCO.2013.49.4757","article-title":"Use of statins and the risk of death in patients with prostate cancer","volume":"32","author":"Azoulay","year":"2014","journal-title":"J Clin Oncol"},{"key":"11","doi-asserted-by":"crossref","first-page":"4652","DOI":"10.1158\/1078-0432.CCR-14-3368","article-title":"Mevalonate Pathway Antagonist Suppresses Formation of Serous Tubal Intraepithelial Carcinoma and Ovarian Carcinoma in Mouse Models","volume":"21","author":"Wang","year":"2015","journal-title":"Clin Cancer Res"},{"key":"12","doi-asserted-by":"publisher","first-page":"47343","DOI":"10.18632\/oncotarget.10121","article-title":"Ovarian tumour growth is characterized by mevalonate pathway gene signature in an orthotopic, syngeneic model of epithelial ovarian cancer","volume":"7","author":"Petrik","year":"2016","journal-title":"Oncotarget"},{"key":"13","doi-asserted-by":"publisher","first-page":"946","DOI":"10.18632\/oncotarget.5834","article-title":"The HMG-CoA reductase inhibitor, simvastatin, exhibits anti-metastatic and anti-tumorigenic effects in ovarian cancer","volume":"7","author":"Bae-Jump","year":"2016","journal-title":"Oncotarget"},{"key":"14","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/mrd.10175","article-title":"Mouse transgenic for murine oviduct-specific glycoprotein promoter-driven simian virus 40 large T-antigen: tumor formation and its hormonal regulation","volume":"63","author":"Kasai","year":"2002","journal-title":"Mol Reprod Dev"},{"key":"15","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/path.4353","article-title":"A genetically engineered ovarian cancer mouse model based on fallopian tube transformation mimics human high-grade serous carcinoma development","volume":"233","author":"Becker","year":"2014","journal-title":"J Pathol"},{"key":"16","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1097\/PAS.0b013e31825ec07a","article-title":"The diagnostic and biological implications of laminin expression in serous tubal intraepithelial carcinoma","volume":"36","author":"Shih Ie","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"17","doi-asserted-by":"crossref","first-page":"671","DOI":"10.3109\/1354750X.2012.715672","article-title":"Glutathione levels in human tumors","volume":"17","author":"Colvin","year":"2012","journal-title":"Biomarkers"},{"key":"18","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nrd2803","article-title":"Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?","volume":"8","author":"Huang","year":"2009","journal-title":"Nat Rev Drug Discov"},{"key":"19","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1080\/10715760802317663","article-title":"Glutathione and apoptosis","volume":"42","author":"Aw","year":"2008","journal-title":"Free Radic Res"},{"key":"20","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.4161\/auto.22037","article-title":"Glutathione participates in the modulation of starvation-induced autophagy in carcinoma cells","volume":"8","author":"Ciriolo","year":"2012","journal-title":"Autophagy"},{"key":"21","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.biocel.2012.04.024","article-title":"From tumor cell metabolism to tumor immune escape","volume":"45","author":"Allende-Vega","year":"2013","journal-title":"Int J Biochem Cell Biol"},{"key":"22","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12943-016-0555-x","article-title":"Cancer stem cell metabolism: a potential target for cancer therapy","volume":"15","author":"Dharmarajan","year":"2016","journal-title":"Mol Cancer"},{"key":"23","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.1242\/jcs.181016","article-title":"Cancer metabolism at a glance","volume":"129","author":"Gottlieb","year":"2016","journal-title":"J Cell Sci"},{"key":"24","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1007\/s11306-012-0452-2","article-title":"Metabolomic profiling of lung and prostate tumor tissues by capillary electrophoresis time-of-flight mass spectrometry","volume":"9","author":"Tomita","year":"2013","journal-title":"Metabolomics"},{"key":"25","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/nature14363","article-title":"SHMT2 drives glioma cell survival in ischaemia but imposes a dependence on glycine clearance","volume":"520","author":"Kwon","year":"2015","journal-title":"Nature"},{"key":"26","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1158\/0008-5472.CAN-14-1560","article-title":"Lysine Demethylase LSD1 Coordinates Glycolytic and Mitochondrial Metabolism in Hepatocellular Carcinoma Cells","volume":"75","author":"Nakao","year":"2015","journal-title":"Cancer Res"},{"key":"27","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2174\/156800906775471743","article-title":"Anti-cancer therapy: targeting the mevalonate pathway","volume":"6","author":"Hohl","year":"2006","journal-title":"Curr Cancer Drug Targets"},{"key":"28","doi-asserted-by":"crossref","first-page":"563","DOI":"10.2174\/1568009616666151203224603","article-title":"Protein Geranylgeranyltransferase Type 1 as a Target in Cancer","volume":"16","author":"Casey","year":"2016","journal-title":"Curr Cancer Drug Targets"},{"key":"29","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/acel.12351","article-title":"Retinoblastoma protein promotes oxidative phosphorylation through upregulation of glycolytic genes in oncogene-induced senescent cells","volume":"14","author":"Nakao","year":"2015","journal-title":"Aging Cell"},{"key":"30","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1101\/gad.211326.112","article-title":"The retinoblastoma protein induces apoptosis directly at the mitochondria","volume":"27","author":"Lees","year":"2013","journal-title":"Genes Dev"},{"key":"31","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1126\/science.123.3191.309","article-title":"On the origin of cancer cells","volume":"123","author":"Warburg","year":"1956","journal-title":"Science"},{"key":"32","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1146\/annurev-cellbio-092910-154237","article-title":"Aerobic glycolysis: meeting the metabolic requirements of cell proliferation","volume":"27","author":"Vander Heiden","year":"2011","journal-title":"Annu Rev Cell Dev Biol"},{"key":"33","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: the metabolic requirements of cell proliferation","volume":"324","author":"Thompson","year":"2009","journal-title":"Science"},{"key":"34","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ccr.2012.02.014","article-title":"Metabolic reprogramming: a cancer hallmark even warburg did not anticipate","volume":"21","author":"Thompson","year":"2012","journal-title":"Cancer Cell"},{"key":"35","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","article-title":"Drug combination studies and their synergy quantification using the Chou-Talalay method","volume":"70","author":"Chou","year":"2010","journal-title":"Cancer Res"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.20046","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T11:19:03Z","timestamp":1589195943000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.20046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,7]]},"references-count":35,"journal-issue":{"issue":"42","published-print":{"date-parts":[[2017,9,22]]}},"alternative-id":["20046","29069775"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.20046","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,7]]}}}